Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
DEXCOM INC
Report date March 31, 2017 · Filed April 20, 2017
Section 16 reporting ended · disclosed 2017-04-20. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 13, 2017 Filed Mar 14, 2017 23:59 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 14,400 | $77.74 | $1,119,513.60 |
DisclosureSEC source: 0001093557-17-000076 · edgardoc.xml · nonDerivative · entry 10 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 10,442 F6 · shares: On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F7 · price: This transaction was executed in multiple trades at prices ranging from $77.41 to $78.39. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F4 · balance_after: Shares are held by the Jorge Alberto Valdes and Suzanne Lopez-Calleja, cotrustees of the Valdes-Lopez-Calleja Family Trust, dated May 18, 2011. F5 · ownership.nature: Shares are held by the Valdes-Lopez-Calleja Family Trust U/A/D 05/18/2011, with respect to which the reporting person is a trustee. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 23:59 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 3,964 | $77.55 | $307,410.58 |
DisclosureSEC source: 0001093557-17-000076 · edgardoc.xml · nonDerivative · entry 9 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 24,842 F3 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F4 · balance_after: Shares are held by the Jorge Alberto Valdes and Suzanne Lopez-Calleja, cotrustees of the Valdes-Lopez-Calleja Family Trust, dated May 18, 2011. F5 · ownership.nature: Shares are held by the Valdes-Lopez-Calleja Family Trust U/A/D 05/18/2011, with respect to which the reporting person is a trustee. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 23:59 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 6,694 | $77.55 | $519,123.72 |
DisclosureSEC source: 0001093557-17-000076 · edgardoc.xml · nonDerivative · entry 8 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 28,806 F3 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F4 · balance_after: Shares are held by the Jorge Alberto Valdes and Suzanne Lopez-Calleja, cotrustees of the Valdes-Lopez-Calleja Family Trust, dated May 18, 2011. F5 · ownership.nature: Shares are held by the Valdes-Lopez-Calleja Family Trust U/A/D 05/18/2011, with respect to which the reporting person is a trustee. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 23:59 UTC | DEXCOM INC DXCM · Entity 3114 | OtherCommon Stock | 12,667 | $78.24 | $991,066.08 |
DisclosureSEC source: 0001093557-17-000076 · edgardoc.xml · nonDerivative · entry 7 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 35,500 F1 · shares: Shares were transferred from direct ownership to ownership under the Valdes-Lopez-Calleja Family Trust upon vesting of previously awarded restricted stock units. F4 · balance_after: Shares are held by the Jorge Alberto Valdes and Suzanne Lopez-Calleja, cotrustees of the Valdes-Lopez-Calleja Family Trust, dated May 18, 2011. F5 · ownership.nature: Shares are held by the Valdes-Lopez-Calleja Family Trust U/A/D 05/18/2011, with respect to which the reporting person is a trustee. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 23:59 UTC | DEXCOM INC DXCM · Entity 3114 | OtherCommon Stock | 7,500 | $78.24 | $586,800.00 |
DisclosureSEC source: 0001093557-17-000076 · edgardoc.xml · nonDerivative · entry 6 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 22,833 F1 · shares: Shares were transferred from direct ownership to ownership under the Valdes-Lopez-Calleja Family Trust upon vesting of previously awarded restricted stock units. F4 · balance_after: Shares are held by the Jorge Alberto Valdes and Suzanne Lopez-Calleja, cotrustees of the Valdes-Lopez-Calleja Family Trust, dated May 18, 2011. F5 · ownership.nature: Shares are held by the Valdes-Lopez-Calleja Family Trust U/A/D 05/18/2011, with respect to which the reporting person is a trustee. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 23:59 UTC | DEXCOM INC DXCM · Entity 3114 | OtherCommon Stock | 11,834 | $78.24 | $925,892.16 |
DisclosureSEC source: 0001093557-17-000076 · edgardoc.xml · nonDerivative · entry 5 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 15,333 F1 · shares: Shares were transferred from direct ownership to ownership under the Valdes-Lopez-Calleja Family Trust upon vesting of previously awarded restricted stock units. F4 · balance_after: Shares are held by the Jorge Alberto Valdes and Suzanne Lopez-Calleja, cotrustees of the Valdes-Lopez-Calleja Family Trust, dated May 18, 2011. F5 · ownership.nature: Shares are held by the Valdes-Lopez-Calleja Family Trust U/A/D 05/18/2011, with respect to which the reporting person is a trustee. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 23:59 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 6,254 | $77.55 | $485,001.45 |
DisclosureSEC source: 0001093557-17-000076 · edgardoc.xml · nonDerivative · entry 4 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,079 F3 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F4 · balance_after: Shares are held by the Jorge Alberto Valdes and Suzanne Lopez-Calleja, cotrustees of the Valdes-Lopez-Calleja Family Trust, dated May 18, 2011. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 23:59 UTC | DEXCOM INC DXCM · Entity 3114 | OtherCommon Stock | 12,667 | $78.24 | $991,066.08 |
DisclosureSEC source: 0001093557-17-000076 · edgardoc.xml · nonDerivative · entry 3 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,333 F1 · shares: Shares were transferred from direct ownership to ownership under the Valdes-Lopez-Calleja Family Trust upon vesting of previously awarded restricted stock units. F2 · balance_after: Included in this number are 40,333 unvested restricted stock units, 25,333 of which were granted on March 8, 2016 and shall vest through March 8, 2019 and 15,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 23:59 UTC | DEXCOM INC DXCM · Entity 3114 | OtherCommon Stock | 7,500 | $78.24 | $586,800.00 |
DisclosureSEC source: 0001093557-17-000076 · edgardoc.xml · nonDerivative · entry 2 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,000 F1 · shares: Shares were transferred from direct ownership to ownership under the Valdes-Lopez-Calleja Family Trust upon vesting of previously awarded restricted stock units. F2 · balance_after: Included in this number are 40,333 unvested restricted stock units, 25,333 of which were granted on March 8, 2016 and shall vest through March 8, 2019 and 15,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 23:59 UTC | DEXCOM INC DXCM · Entity 3114 | OtherCommon Stock | 11,834 | $78.24 | $925,892.16 |
DisclosureSEC source: 0001093557-17-000076 · edgardoc.xml · nonDerivative · entry 1 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,500 F1 · shares: Shares were transferred from direct ownership to ownership under the Valdes-Lopez-Calleja Family Trust upon vesting of previously awarded restricted stock units. F2 · balance_after: Included in this number are 40,333 unvested restricted stock units, 25,333 of which were granted on March 8, 2016 and shall vest through March 8, 2019 and 15,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018. Read SEC document |
| February 09, 2017 Filed Feb 14, 2017 00:18 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,000 | $79.76 Strike: $9.80 | $558,315.80 |
DisclosureSEC source: 0001093557-17-000028 · edgardoc.xml · derivative · entry 4 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2020-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2017 Filed Feb 14, 2017 00:18 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 7,000 | $79.76 | $558,315.80 |
DisclosureSEC source: 0001093557-17-000028 · edgardoc.xml · nonDerivative · entry 2 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 F1 · shares: On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $79.40 to $80.48. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| February 09, 2017 Filed Feb 14, 2017 00:18 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionCommon Stock | 7,000 | $9.80 | $68,600.00 |
DisclosureSEC source: 0001093557-17-000028 · edgardoc.xml · nonDerivative · entry 1 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:49 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 13,900 | $80.00 Strike: $9.80 | $1,112,000.00 |
DisclosureSEC source: 0001093557-17-000023 · edgardoc.xml · derivative · entry 4 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 13,900 shares Expires 2020-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:49 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 13,900 | $80.00 | $1,112,000.00 |
DisclosureSEC source: 0001093557-17-000023 · edgardoc.xml · nonDerivative · entry 2 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 F1 · shares: On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:49 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionCommon Stock | 13,900 | $9.80 | $136,220.00 |
DisclosureSEC source: 0001093557-17-000023 · edgardoc.xml · nonDerivative · entry 1 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2017 Filed Jan 19, 2017 00:37 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,173 | $80.00 Strike: $9.80 | $573,840.00 |
DisclosureSEC source: 0001093557-17-000012 · edgardoc.xml · derivative · entry 10 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,900 Underlying: Common Stock · 7,173 shares Expires 2020-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2017 Filed Jan 19, 2017 00:37 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 8,927 | $80.00 Strike: $9.80 | $714,160.00 |
DisclosureSEC source: 0001093557-17-000012 · edgardoc.xml · derivative · entry 9 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,927 shares Expires 2020-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2017 Filed Jan 19, 2017 00:37 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 10,000 | $80.00 Strike: $7.63 | $800,000.00 |
DisclosureSEC source: 0001093557-17-000012 · edgardoc.xml · derivative · entry 8 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2018-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2017 Filed Jan 19, 2017 00:37 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 7,173 | $80.00 | $573,840.00 |
DisclosureSEC source: 0001093557-17-000012 · edgardoc.xml · nonDerivative · entry 6 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 F1 · shares: On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| January 13, 2017 Filed Jan 19, 2017 00:37 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionCommon Stock | 7,173 | $9.80 | $70,295.40 |
DisclosureSEC source: 0001093557-17-000012 · edgardoc.xml · nonDerivative · entry 5 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2017 Filed Jan 19, 2017 00:37 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 10,000 | $80.00 | $800,000.00 |
DisclosureSEC source: 0001093557-17-000012 · edgardoc.xml · nonDerivative · entry 4 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 F1 · shares: On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| January 13, 2017 Filed Jan 19, 2017 00:37 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionCommon Stock | 10,000 | $7.63 | $76,300.00 |
DisclosureSEC source: 0001093557-17-000012 · edgardoc.xml · nonDerivative · entry 3 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2017 Filed Jan 19, 2017 00:37 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 8,927 | $80.00 | $714,160.00 |
DisclosureSEC source: 0001093557-17-000012 · edgardoc.xml · nonDerivative · entry 2 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 F1 · shares: On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| January 13, 2017 Filed Jan 19, 2017 00:37 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionCommon Stock | 8,927 | $9.80 | $87,484.60 |
DisclosureSEC source: 0001093557-17-000012 · edgardoc.xml · nonDerivative · entry 1 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 900 | $63.00 | $56,700.00 |
DisclosureSEC source: 0001093557-17-000006 · edgardoc.xml · derivative · entry 13 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 Underlying: Common Stock · 900 shares Expires 2018-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Conversion or exercise price of derivative security is $3.19. Read SEC document |
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,583 | $62.83 Strike: $7.63 | $162,287.57 |
DisclosureSEC source: 0001093557-17-000006 · edgardoc.xml · derivative · entry 12 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,583 shares Expires 2018-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 7,000 | $63.02 Strike: $7.79 | $441,162.40 |
DisclosureSEC source: 0001093557-17-000006 · edgardoc.xml · derivative · entry 11 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2017-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 417 | $63.49 Strike: $7.63 | $26,474.29 |
DisclosureSEC source: 0001093557-17-000006 · edgardoc.xml · derivative · entry 10 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 417 shares Expires 2018-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 2,583 | $62.83 | $162,287.57 |
DisclosureSEC source: 0001093557-17-000006 · edgardoc.xml · nonDerivative · entry 8 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 F1 · shares: On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $62.49 to $63.17. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionCommon Stock | 2,583 | $7.63 | $19,708.29 |
DisclosureSEC source: 0001093557-17-000006 · edgardoc.xml · nonDerivative · entry 7 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,917 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 900 | $63.31 | $56,980.62 |
DisclosureSEC source: 0001093557-17-000006 · edgardoc.xml · nonDerivative · entry 6 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 F1 · shares: On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $63.17 to $63.37. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionCommon Stock | 900 | $3.19 | $2,871.00 |
DisclosureSEC source: 0001093557-17-000006 · edgardoc.xml · nonDerivative · entry 5 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 417 | $63.49 | $26,474.29 |
DisclosureSEC source: 0001093557-17-000006 · edgardoc.xml · nonDerivative · entry 4 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 F1 · shares: On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $63.37 to $63.65. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionCommon Stock | 417 | $7.63 | $3,181.71 |
DisclosureSEC source: 0001093557-17-000006 · edgardoc.xml · nonDerivative · entry 3 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 7,000 | $63.02 | $441,162.40 |
DisclosureSEC source: 0001093557-17-000006 · edgardoc.xml · nonDerivative · entry 2 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 F1 · shares: On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $62.48 to $63.71. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionCommon Stock | 7,000 | $7.79 | $54,530.00 |
DisclosureSEC source: 0001093557-17-000006 · edgardoc.xml · nonDerivative · entry 1 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 21:21 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,925 | $64.81 Strike: $7.79 | $254,371.01 |
DisclosureSEC source: 0001093557-16-000758 · edgardoc.xml · derivative · entry 10 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,925 shares Expires 2017-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 21:21 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 2,637 | $64.81 Strike: $7.79 | $170,898.43 |
DisclosureSEC source: 0001093557-16-000758 · edgardoc.xml · derivative · entry 9 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 2,637 shares Expires 2017-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 21:21 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 3,438 | $64.81 Strike: $7.25 | $222,809.56 |
DisclosureSEC source: 0001093557-16-000758 · edgardoc.xml · derivative · entry 8 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,438 shares Expires 2017-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 21:21 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 3,925 | $64.81 | $254,371.01 |
DisclosureSEC source: 0001093557-16-000758 · edgardoc.xml · nonDerivative · entry 6 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 F1 · shares: On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 21:21 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionCommon Stock | 3,925 | $7.79 | $30,575.75 |
DisclosureSEC source: 0001093557-16-000758 · edgardoc.xml · nonDerivative · entry 5 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,259 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 21:21 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 3,438 | $64.81 | $222,809.56 |
DisclosureSEC source: 0001093557-16-000758 · edgardoc.xml · nonDerivative · entry 4 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 F1 · shares: On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 21:21 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionCommon Stock | 3,438 | $7.25 | $24,925.50 |
DisclosureSEC source: 0001093557-16-000758 · edgardoc.xml · nonDerivative · entry 3 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,772 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 21:21 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 2,637 | $64.81 | $170,898.43 |
DisclosureSEC source: 0001093557-16-000758 · edgardoc.xml · nonDerivative · entry 2 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 F1 · shares: On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 21:21 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionCommon Stock | 2,637 | $7.79 | $20,542.23 |
DisclosureSEC source: 0001093557-16-000758 · edgardoc.xml · nonDerivative · entry 1 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,971 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 10, 2016 Filed Oct 13, 2016 00:57 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 11,000 | $84.42 Strike: $7.63 | $928,579.30 |
DisclosureSEC source: 0001093557-16-000722 · edgardoc.xml · derivative · entry 4 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,583 Underlying: Common Stock · 11,000 shares Expires 2018-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 10, 2016 Filed Oct 13, 2016 00:57 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 11,000 | $84.42 | $928,579.30 |
DisclosureSEC source: 0001093557-16-000722 · edgardoc.xml · nonDerivative · entry 2 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 F1 · shares: On March 7, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $83.52 to $84.97. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest on March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. Read SEC document |
| October 10, 2016 Filed Oct 13, 2016 00:57 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionCommon Stock | 11,000 | $7.63 | $83,930.00 |
DisclosureSEC source: 0001093557-16-000722 · edgardoc.xml · nonDerivative · entry 1 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 00:30 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 7,071 | $92.06 | $650,964.75 |
DisclosureSEC source: 0001093557-16-000691 · edgardoc.xml · nonDerivative · entry 9 VALDES JORGE A · CIK 0001343856 · CTO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 3,499 F7 · price: This transaction was executed in multiple trades at prices ranging from $92.06 to $92.07. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F5 · ownership.nature: Shares are held by the Valdes-Lopez-Calleja Family Trust U/A/D 05/18/2011, with respect to which the reporting person is a trustee. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.